51 related articles for article (PubMed ID: 20843140)
1. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors affecting survival and recurrence in patients with early cervical squamous cell cancer following radical hysterectomy.
Li D; Xu X; Yan D; Yuan S; Ni J; Lou H
J Int Med Res; 2020 Apr; 48(4):300060519889741. PubMed ID: 31889461
[TBL] [Abstract][Full Text] [Related]
3. Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042).
Hwang WY; Choi CH; Kim K; Kim MH; Lim MC; Lee B; Kim M; Kim YH; Seong SJ; Lee JM
Obstet Gynecol Sci; 2024 May; 67(3):296-303. PubMed ID: 38484700
[TBL] [Abstract][Full Text] [Related]
4. Small volume stage 1B1 cervical cancer: Is radical surgery still necessary?
Biliatis I; Kucukmetin A; Patel A; Ratnavelu N; Cross P; Chattopadhyay S; Galaal K; Naik R
Gynecol Oncol; 2012 Jul; 126(1):73-7. PubMed ID: 22465521
[TBL] [Abstract][Full Text] [Related]
5. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer.
Doll KM; Donnelly E; Helenowski I; Rosenbloom L; Small W; Schink JC; Lurain JR
Am J Clin Oncol; 2014 Feb; 37(1):30-4. PubMed ID: 22992622
[TBL] [Abstract][Full Text] [Related]
6. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.
Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S78-84. PubMed ID: 23519309
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy.
Ito H; Shigematsu N; Kawada T; Kubo A; Isobe K; Hara R; Yasuda S; Aruga T; Ogata H
Gynecol Oncol; 1997 Nov; 67(2):154-61. PubMed ID: 9367699
[TBL] [Abstract][Full Text] [Related]
8. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
Schorge JO; Molpus KL; Koelliker D; Nikrui N; Goodman A; Fuller AF
Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
[TBL] [Abstract][Full Text] [Related]
9. Site of recurrence of cervical cancer after radical hysterectomy.
Webb MJ; Symmonds RE
Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):813-7. PubMed ID: 7446614
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab Efficacy and Recurrence Pattern of Persistent and Metastatic Cervical Cancer.
Lee N; Kim SI; Lee M; Kim HS; Kim JW; Park NH; Song YS
In Vivo; 2019; 33(3):863-868. PubMed ID: 31028209
[TBL] [Abstract][Full Text] [Related]
11. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
[TBL] [Abstract][Full Text] [Related]
12. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
14. Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma.
Samlal RA; van der Velden J; Schilthuis MS; González González D; Ten Kate FJ; Hart AA; Lammes FB
Gynecol Oncol; 1997 Mar; 64(3):463-7. PubMed ID: 9062151
[TBL] [Abstract][Full Text] [Related]
15. Recurrence patterns after radical hysterectomy in stage IB1-IIA cervical.
Sittidilokratna K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2010; 11(2):499-502. PubMed ID: 20843140
[TBL] [Abstract][Full Text] [Related]
16. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
